A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD.

ABSTRACT:

Introduction

Thyroid hormones can directly affect kidney function; elevated levels of thyroid-stimulating hormone (TSH) and chronic kidney disease (CKD) are associated with proteinuria, decreased estimated glomerular filtration rate (eGFR), and progression to end-stage renal disease. Our hypothesis is that in patients with CKD and TSH at levels considered to be in the low subclinical hypothyroidism (SCH) range, lowering TSH with levothyroxine (LVX) improves the clinical parameters of renal function.

Methods

This was a double-blind, randomized, pilot clinical trial in patients with proteinuric CKD (eGFR <60 ml/min per 1.73 m² and proteinuria >150 mg/d) performed at the Hospital Civil de Guadalajara, with the intention of lowering TSH (levels of 1.25-2.5 μIU/l) in p

SUBMITTER: Blackaller GN 

PROVIDER: S-EPMC7783574 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature